Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Clinical trial NCT03248882 · COMPLETED
Trial details
- NCT number
- NCT03248882
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-22
- Primary completion
- 2019-02-26
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.